All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| TUYA / Tuya Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| INZY / Inozyme Pharma, Inc.
|
|
|
|
|
|
|
|
| CSBR / Champions Oncology, Inc.
|
|
|
|
|
|
|
|
| CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
| ZFOX / ZeroFox Holdings, Inc.
|
|
|
|
|
|
|
|
| RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
| CELC / Celcuity Inc.
|
|
|
|
|
|
|
|
| COUR / Coursera, Inc.
|
|
|
|
|
|
|
|
| CVRX / CVRx, Inc.
|
|
|
|
|
|
|
|
| UP / Wheels Up Experience Inc.
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MRKR / Marker Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
| VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RPHM / Reneo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
| DMYI.U / dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f
|
|
|
|
|
|
|
|
| PANW / Palo Alto Networks, Inc.
|
|
|
|
|
|
|
|
| US0846561076 / Berkshire Grey, Inc.
|
|
|
|
|
|
|
|
| EAR / Eargo, Inc.
|
|
|
|
|
|
|
|
| XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
| GERN / Geron Corporation
|
|
|
|
|
|
|
|
| ACRV / Acrivon Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
| GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
| NN / NextNav Inc.
|
|
|
|
|
|
|
|
| LXRX / Lexicon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SNTI / Senti Biosciences, Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MIMO / Airspan Networks Holdings Inc.
|
|
|
|
|
|
|
|
| STSA / Satsuma Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| NET / Cloudflare, Inc.
|
|
|
|
|
|
|
|
| CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
| AIRSPAN NETWORKS HOLDINGS INC
/ *W EXP 08/13/2023 (00951K120) |
|
|
|
|
|
|
|
| MIMO.WSB / Airspan Networks Holdings Inc. Warrants, each whole warrant exercisable for one share of common stoc
|
|
|
|
|
|
|
|
| NOTE / FiscalNote Holdings, Inc.
|
|
|
|
|
|
|
|
| OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
| BZFD / BuzzFeed, Inc.
|
|
|
|
|
|
|
|
| AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| BDTX / Black Diamond Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| UTRS / Minerva Surgical, Inc.
|
|
|
|
|
|
|
|
| RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
| NEUE / NeueHealth, Inc.
|
|
|
|
|
|
|
|
